Welcome to 2024

The Future of Hemostasis Management: Exploring the Clinical Benefits of ClotPro TPA-Test

Concentration–effect relationship for tranexamic acid inhibition of tissue plasminogen activator-induced fibrinolysis in vitro using the viscoelastic ClotPro® TPA-test

Fibrinolytic Potential

The effect of t-PA on fibrinolytic resistance in a patient with portal vein thrombosis

The Intrinsic Pathway

Clever Clotting

ANZCA 2023 Sydney

Improving time to thrombolysis in stroke

Fibrinolysis resistance in the critically ill

Paediatric ClotPro® thromboelastometry device reference ranges are out!

TGA Listing for new Viscoelastic Test on ClotPro

Thrombolysis in ARDS

Can We Improve on the Rapid Assessment of Clinically Relevant Levels of DOACS?

Trial of intravenous nafamostat mesylate in COVID pneumonitis:

Merry Christmas

Coagulation Monitoring in ECMO

ASA Nonresponse in Vascular Surgery

VITT Functional Testing

Effects of lignocaine on anti-platelet activity: the LOCAL trial

Another great outcome using #Multiplate

Why Me? To Be an Ultra-Responder to Antiplatelet Therapy: A Case Report

Impact of Idarucizumab and Andexanet Alfa on DOAC Plasma Concentration and ClotPro®

Perioperative Coagulation Monitoring

Viscoelastometry for detecting oral anticoagulants

Greater Fibrinolysis Resistance but No Greater Platelet Aggregation in COVID Patients

Good Platelets gone bad

National Blood Authority Recognises DOASENSE for detection of direct anticoagulants

NATA Update

Fibrinogen in Trauma

The most advanced device on the market

VITT Testing

Functional Platelet Testing

The latest in POC Direct Oral Anticoagulant testing using the DOASENSE

ISTH 2020 Virtual Congress

TGA Listing

Fibrinogen Supplementation and Its Indications